American International Group, Inc. Nuvectis Pharma, Inc. Transaction History
American International Group, Inc.
- $27.6 Billion
- Q1 2024
A detailed history of American International Group, Inc. transactions in Nuvectis Pharma, Inc. stock. As of the latest transaction made, American International Group, Inc. holds 3,664 shares of NVCT stock, worth $23,852. This represents 0.0% of its overall portfolio holdings.
Number of Shares
3,664
Previous 3,695
0.84%
Holding current value
$23,852
Previous $30,000
-0.0%
% of portfolio
0.0%
Previous 0.0%
Shares
4 transactions
Others Institutions Holding NVCT
# of Institutions
39Shares Held
2.11MCall Options Held
0Put Options Held
0-
Ronit Capital LLP563KShares$3.66 Million5.37% of portfolio
-
Black Rock Inc. New York, NY373KShares$2.43 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA299KShares$1.95 Million0.0% of portfolio
-
Baldwin Brothers LLC154KShares$1 Million0.1% of portfolio
-
Geode Capital Management, LLC Boston, MA135KShares$875,7770.0% of portfolio
About Nuvectis Pharma, Inc.
- Ticker NVCT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 14,642,500
- Market Cap $95.3M
- Description
- Nuvectis Pharma, Inc., a biopharmaceutical company, focuses on the development of precision medicines for the treatment of serious unmet medical needs in oncology. It develops NXP800, a novel heat shock factor 1 pathway inhibitor for the treatment of various cancers; and NXP900, a small molecule drug candidate to inhibit the Proto-oncogene c-Src...